Arul M Chinnaiyan
S P Hicks Endowed Professor of Pathology
Section Head
Michigan Center for Translational Pathology
Professor of Pathology and Professor of Urology
[email protected]

Available to mentor
Arul M Chinnaiyan
Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      MM-PKUHSC Joint Institute
    • Center Member
      Taubman Institute
    • Center Member
      Precision Health Initiative
    • Center Member
      Global REACH
    • Center Member
      Rogel Cancer Center
    • Center Member
      Center for Computational Medicine and Bioinformatics
    Recent Publications See All Publications
    • Journal Article
      Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.
      Messinger D, Harris MK, Cummings JR, Thomas C, Yang T, Sweha SR, Woo R, Siddaway R, Burkert M, Stallard S, Qin T, Mullan B, Siada R, Ravindran R, Niculcea M, Dowling AR, Bradin J, Ginn KF, Gener MAH, Dorris K, Vitanza NA, Schmidt SV, Spitzer J, Li J, Filbin MG, Cao X, Castro MG, Lowenstein PR, Mody R, Chinnaiyan A, Desprez P-Y, McAllister S, Dun MD, Hawkins C, Waszak SM, Venneti S, Koschmann C, Yadav VN. Neuro Oncol, 2023 Jan 5; 25 (1): 54 - 67. DOI:10.1093/neuonc/noac141
      PMID: 35605606
    • Journal Article
      CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue.
      van Riet J, Saha C, Strepis N, Brouwer RWW, Martens-Uzunova ES, van de Geer WS, Swagemakers SMA, Stubbs A, Halimi Y, Voogd S, Tanmoy AM, Komor MA, Hoogstrate Y, Janssen B, Fijneman RJA, Niknafs YS, Chinnaiyan AM, van IJcken WFJ, van der Spek PJ, Jenster G, Louwen R. Commun Biol, 2022 Apr 8; 5 (1): 338 DOI:10.1038/s42003-022-03249-4
      PMID: 35396392
    • Journal Article
      Adolescent and parent perspectives on genomic sequencing to inform cancer care.
      Sedig LK, Jacobs MF, Mody RJ, Le LQ, Bartnik NJ, Gornick MC, Anderson B, Chinnaiyan AM, Roberts JS. Pediatr Blood Cancer, 2022 Sep; 69 (9): e29791 DOI:10.1002/pbc.29791
      PMID: 35735208
    • Preprint
      MyProstateScore in Men Considering Repeat Biopsy: Validation of a Simple Testing Approach
      Tosoian J, Sessine M, Trock B, Ross A, Xie C, Zheng Y, Samora N, Siddiqui J, Niknafs Y, Chopra Z, Tomlins S, Kunju L, Palapattu G, Morgan T, Wei J, Salami S, Chinnaiyan A. 2022 Research Square, DOI:10.21203/rs.3.rs-1728404/v1
    • Journal Article
      Abstract 2538: Role of Argonaute 2 in regulation of immune microenvironment in pancreatic cancer
      Hon J, Kenum C, Bawa PS, Dommeti VL, Sahu AA, Gandham M, Li C-C, Taher ZI, Zelenka-Wang S, Tien JC, Shankar S, Chugh S, Chinnaiyan AM. Cancer Research, 2022 Jun 15; 82 (12_Supplement): 2538 - 2538. DOI:10.1158/1538-7445.am2022-2538
    • Journal Article
      Abstract 3383: Circular RNAs as non-invasive diagnostic biomarkers for prostate cancer
      Shah P, Bawa P, Xiao L, Kleyman Y, Vo J, Dhanasekaran SM, Brown J, Loeding N, Koons A, Siddiqui J, Cao X, Chinnaiyan AM. Cancer Research, 2022 Jun 15; 82 (12_Supplement): 3383 - 3383. DOI:10.1158/1538-7445.am2022-3383
    • Journal Article
      Abstract 5274: Mechanisms of action (MOA) for proxalutamide, an androgen receptor (AR) antagonist, for the treatment of mild, moderate and severe COVID-19 patients
      Ma L, Tong Y, Zhou Q, Yan H, Hou X, Ren Z, Li J, Wang H, Qian W, Zhang Y, Goren A, Chinnaiyan A. Cancer Research, 2022 Jun 15; 82 (12_Supplement): 5274 - 5274. DOI:10.1158/1538-7445.am2022-5274
    • Journal Article
      Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.
      Dadhania V, Gonzalez D, Yousif M, Cheng J, Morgan TM, Spratt DE, Reichert ZR, Mannan R, Wang X, Chinnaiyan A, Cao X, Dhanasekaran SM, Chinnaiyan AM, Pantanowitz L, Mehra R. BMC Cancer, 2022 May 5; 22 (1): 494 DOI:10.1186/s12885-022-09559-4
      PMID: 35513774
    Featured News & Stories frozen dial with ice on it with red dial
    Health Lab
    Enzyme identified as new therapeutic target for “cold” tumors
    A study identifies an enzyme as a new therapeutic target for “cold” tumors.
         Sewing Machine Cell Fabric Tangled
    Health Lab
    Research points to potential new treatment for aggressive prostate cancer subtype
    In two separate papers, U-M researchers describe how a gene alteration drives prostate cancer and a potential degrader that stops it
         blue cells close up with orangey see through circle going in and an explosion of bright yellow orange to the far left in that circle with purple circles floating in background
    Health Lab
    Researchers identify factor that drives prostate cancer-causing genes
    Researchers have uncovered a key reason why a typically normal protein goes awry and fuels cancer. They found the protein NSD2 alters the function of the androgen receptor, an important regulator of normal prostate development.
         blue purple cell dots on white background all over in different patterns
    Health Lab
    Research finds possible therapies to target oncogenic transcription factors in multiple cancer types
    A study from the University of Michigan Health Rogel Cancer Center furthers research that suggests the potential of developing new cancer treatments to target oncogenic transcription factors by indirectly affecting their ability to access enhancer DNA in chromatin.